CEM Corporation v. Personal Chemistry

55 F. App'x 621
CourtCourt of Appeals for the Fourth Circuit
DecidedJanuary 15, 2003
Docket02-1369
StatusUnpublished
Cited by11 cases

This text of 55 F. App'x 621 (CEM Corporation v. Personal Chemistry) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
CEM Corporation v. Personal Chemistry, 55 F. App'x 621 (4th Cir. 2003).

Opinion

OPINION

PER CURIAM.

In December 2000, CEM Corporation, a North Carolina corporation, filed suit in Sweden against Personal Chemistry, AB, *623 a Swedish corporation with its principal place of business in Sweden that has never registered to do business in North Carolina. CEM alleged that Personal Chemistry infringed a European patent belonging to CEM. A month later, several employees of Personal Chemistry and its United States affiliate traveled to North Carolina to attempt to settle the Swedish patent infringement action with CEM officials. The two sides negotiated an “agreement-in-principle,” which provided for dismissal of the Swedish litigation and a license to Personal Chemistry for the patent' at issue and another European patent in exchange for a one-time payment of $700,000 by Personal Chemistry to CEM. Personal Chemistry’s board of directors, however, subsequently refused to approve the agreement-in-principle.

CEM then filed the present action in North Carolina against Personal Chemistry, alleging breach of the agreement-in-principle, intentional and negligent misrepresentation, and unfair and deceptive trade practices. On Personal Chemistry’s motion, the district court dismissed the action for lack of personal jurisdiction over Personal Chemistry. See Fed R. Civ. P. 12(b)(2). CEM now appeals.

Because the district court dismissed the complaint without conducting an evidentia-ry hearing, CEM was only required to make a prima facie showing that personal jurisdiction existed. See Mylan Laboratories, Inc. v. Akzo, N.V., 2 F.3d 56, 60 (4th Cir.1993). To carry its burden, CEM had to show that (1) the North Carolina long-arm statute confers personal jurisdiction over Personal Chemistry; and (2) the exercise of personal jurisdiction over Personal Chemistry “comports with the requirements of the Due Process Clause of the Fourteenth Amendment.” Id. As the district court noted, because the North Carolina long-arm statute extends to the limit permissible under the Due Process Clause, Vishay Intertechnology, Inc. v. Delta International Corp., 696 F.2d 1062, 1065 (4th Cir.1982), CEM simply had to demonstrate that Personal Chemistry had sufficient minimum contacts with North Carolina to satisfy due process.

The Supreme Court has articulated two tests for determining whether a defendant’s contacts with a forum suffice to confer personal jurisdiction over the defendant. If the cause of action does not arise from or relate to the defendant’s activities in the forum, a plaintiff must prove that the defendant’s contacts are “continuous and systematic” and so support the exercise of general personal jurisdiction over the defendant. See Helicopteros Nacionales de Colombia v. Hall, 466 U.S. 408, 415-16, 104 S.Ct. 1868, 80 L.Ed.2d 404 (1984). If the cause of action does arise out of or is related to the defendant’s activities within the forum, the plaintiff need only prove that a court has specific personal jurisdiction over a defendant by demonstrating that

(1) the defendant has created a substantial connection to the forum state by action purposefully directed toward the forum state or otherwise invoking the benefits and protections of the laws of the state; and (2) the exercise of jurisdiction based on those minimum contacts would not offend traditional notions of fair play and substantial justice[.]

Lesnick v. Hollingsworth & Vose Co., 35 F.3d 939, 945-46 (4th Cir.1994).

The district court dismissed OEM’s complaint, finding that it failed to make the requisite showing of sufficient contacts to support either general or specific personal jurisdiction over Personal Chemistry. Although CEM apparently disagrees with both holdings, on appeal it only proffers arguments challenging the district court’s *624 refusal to exercise specific personal jurisdiction. 1

CEM first contends that Personal Chemistry’s “contract with CEM,” i.e. the agreement-in-principle that emerged out of the settlement negotiations, in and of itself “subject[s] [Personal Chemistry] to specific personal jurisdiction in North Carolina.” Brief of Appellant at 16. CEM argues that Personal Chemistry’s provisional acceptance of the agreement-in-principle and subsequent asserted breach of and disregard for that agreement, which form the basis of the present action, subject it to specific personal jurisdiction in North Carolina. Assuming, arguendo, that the agreement-in-principle constitutes a binding contract (a point that Personal Chemistry has consistently refused to concede), the Supreme Court has nonetheless expressly considered and rejected such an argument, explaining that “[i]f the question is whether an individual’s contract with an out-of-state party alone can automatically establish sufficient minimum contacts in the other party’s home forum, we believe the answer clearly is that it cannot.” Burger King Corp. v. Rudzewicz, 471 U.S. 462, 478, 105 S.Ct. 2174, 85 L.Ed.2d 528 (1985) (emphasis in original).

CEM fares no better with its argument that the district court could exercise specific personal jurisdiction over Personal Chemistry because, in the agreement-in-principle, Personal Chemistry assertedly undertook “continuing obligations for the life of the patents.” Brief of Appellant at 24. This argument is premised on the licensing agreements for two European patents that constituted part of the agreement-in-principle. As the district court noted, however, these licensing agreements required an up-front, lump-sum payment of royalties rather than continuing or periodic royalty payments. Thus, under the licensing agreements, Personal Chemistry had no “continuing duty to pay royalties or to offer an accounting of products sold incident to a royalty calculation.” Accordingly, the licensing agreements (like the agreement-in-principle itself) had no ongoing connection to North Carolina.

Nor can CEM prevail on its contention that Personal Chemistry purposefully directed other activities toward North Carolina in a way sufficient to establish specific personal jurisdiction. CEM maintains that such “purposefully directed” activities include (1) Personal Chemistry’s actions in negotiating, provisionally agreeing to, and then reneging on the agreement-in-principle; (2) Personal Chemistry’s sales of its product to another company in North Carolina; (3) a seminar given in North Carolina; (4) advertisements on its website combichem.net; (5) participation in trade shows directed, in part, at North Carolina companies; and (6) full page advertisements in various national trade publications.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

North Sails Group, LLC v. Boards & More GMBH
340 Conn. 266 (Supreme Court of Connecticut, 2021)
New Venture Holdings v. Devito Verdi, Inc.
376 F. Supp. 3d 683 (E.D. Virginia, 2019)
Protocol, LLC v. Henderson
18 F. Supp. 3d 689 (M.D. North Carolina, 2014)
Pan-American Products & Holdings, LLC v. R.T.G. Furniture Corp.
825 F. Supp. 2d 664 (M.D. North Carolina, 2011)
Moncrief Oil International, Inc. v. Gazprom
332 S.W.3d 1 (Court of Appeals of Texas, 2011)
Manley v. Air Canada
753 F. Supp. 2d 551 (E.D. North Carolina, 2010)
Smith Architectural Metals, LLC v. American Railing Systems, Inc.
698 S.E.2d 752 (Court of Appeals of North Carolina, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
55 F. App'x 621, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cem-corporation-v-personal-chemistry-ca4-2003.